Login

Stephen Spencer, Managing Director at Houlihan Lokey, shares insights alongside the CEO of Capital Power on industry developments. 00:10:00

Share On Facebook Share On Twitter

Scott Beiser is a Co-Chairman of Houlihan Lokey

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Stefan Björkqvist, CEO of Kallebäck Property Invest, Discusses First North Listing | Stefan Björkqvist, CEO, Kallebäck Property Invest AB.
00:10:00
To consistently grow capital through investment|Clive R Holmes,Managing Partner,Silverfern CoInvestment Partners
00:10:00
Financial Planning: An Essential Guide to Securing Your Future | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
Quebec Precious Metals: Advancing Gold Exploration in James Bay Region
00:10:00
Boryszew's Strong Performance and Future Plans | Wojciech Kowalczyk - CEO of Boryszew Group.
00:10:00
Emerald Resources MD Morgan Hart Presents Progress on Okvau Gold Project
00:10:00
ACM Research - Recognized for Excellence | David Wang, CEO, ACM Research IncACMR:NMQ
00:10:00
Transforming Aberdeen: CEO Stephen Byrd's Optimism Amidst Outflows|Stephen Bird,CEO,Abrdn plc
00:10:00
Insights into API Price Trends & Business Strategy: Aarti Drugs CFO Discusses Market Outlook|Shri Adhish P. Patil,Chief Financial Officer & Chief Operating Officer,Aarti Drugs Ltd.
00:10:00
Deciphering the Market: An Analytical Flash on 2023 Investment Outlook | Jan van Eck, CEO , VanEck.
00:10:00
CDL is a no-fee/no-equity organization that delivers a 9-month objectives-based mentoring program|Sonia Sennik,Executive Director,Creative Destruction Lab
00:10:00
Red Lake Nation Advances Solar Initiative Towards Energy Independence.

© 2026 Nehu